Maha Radhakrishnan – Biography
Last update: 27 days agoExecutive profile
Maha was Executive Partner, Private Equity at Sofinnova Partners, and Consultant at Dyne Therapeutics. Maha Radhakrishnan joined Entrada Therapeutics in 2025.
Maha Radhakrishnan is currentlyExecutive Partner at Sofinnova Investments - View - Sofinnova Investments org chart
Director at Candel Therapeutics - View - Candel Therapeutics org chart
Director at Entrada Therapeutics - View - Entrada Therapeutics org chart
Create your alert
to follow the career of Maha Radhakrishnan.
Education
Maha Radhakrishnan has a Medical Doctor in Internal Medicine from Peoples' Friendship University of Russia.
More about Maha Radhakrishnan
Selected links
Do you need to know more about Maha Radhakrishnan? More results.
Participate
Social media
- Maha Radhakrishnan on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Maha Radhakrishnan
The colleagues of Maha Radhakrishnan
Company Colleagues
- At Sofinnova Investments, Maha Radhakrishnan has 17 colleagues including James Healy (Managing Partner), Eric Delbridge (Portfolio & Public Equity)…
- At Candel Therapeutics, Maha Radhakrishnan has 27 colleagues including Paul-Peter Tak (CEO), Chris Martell (Director)…
- At Entrada Therapeutics, Maha Radhakrishnan has 29 colleagues including Dipal Doshi (CEO), Bernhardt Zeiher (Director)…
Industry Colleagues
- In the Biotechnology industry, Maha Radhakrishnan has 35,753 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Maha Radhakrishnan.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Maha Radhakrishnan.
